TABLE 2.
Multivariable Logistic Regression Model: Preoperative Characteristics c statistic: 0.600
| Patient Characteristics | Adjusted OR | 95% CI | P |
|---|---|---|---|
|
| |||
| Preoperative characteristics | |||
| Age (per 10-y increase) | 1.09 | (1.04–1.15) | 0.0003 |
| Male | 1.19 | (1.10–1.28) | <0.0001 |
| Race (reference: white) | |||
| Black | 1.03 | (0.91–1.18) | 0.6 |
| Asian | 0.65 | (0.49–0.85) | 0.002 |
| Hispanic | 1.03 | (0.77–1.38) | 0.9 |
| Other | 1.02 | (0.76–1.38) | 0.9 |
| Insurance status (reference: medicare/other) | |||
| Medicaid | 1.22 | (1.02–1.45) | 0.03 |
| None/self-pay | 1.03 | (0.76–1.40) | 0.9 |
| Clinical stage (reference: Stage I) | |||
| Stage II | 1.17 | (1.06–1.30) | 0.002 |
| Stage III | 1.08 | (0.93–1.26) | 0.3 |
| Stage IV | 1.28 | (0.95–1.71) | 0.1 |
| BMI | 0.99 | (0.98–0.99) | 0.0002 |
| FEV1% ≤80% predicted | 0.90 | (0.86–0.94) | <0.0001 |
| FEV1% >80% predicted | 0.98 | (0.95–1.01) | 0.2 |
| Cigarette smoking (reference: never smoker) | |||
| Former smoker | 1.09 | (0.96–1.24) | 0.2 |
| Current smoker | 1.20 | (1.04–1.39) | 0.01 |
| Interstitial fibrosis | 1.69 | (1.31–2.19) | <0.0001 |
| Hypertension | 0.98 | (0.90–1.07) | 0.7 |
| Steroids | 1.42 | (1.18–1.72) | 0.0002 |
| Congestive heart failure | 1.03 | (0.79–1.32) | 0.8 |
| Coronary artery disease | 1.15 | (1.04–1.27) | 0.009 |
| Peripheral vascular disease | 1.20 | (1.06–1.37) | 0.004 |
| Cerebrovascular disease | |||
| Transient ischemic attack | 1.12 | (0.94–1.33) | 0.2 |
| Cerebrovascular accident | 1.36 | (1.13–1.63) | 0.001 |
| Diabetes | 1.09 | (0.99–1.19) | 0.07 |
| Induction chemotherapy alone | 0.84 | (0.64–1.10) | 0.2 |
| Induction chemoradiation therapy | 1.32 | (0.97–1.81) | 0.08 |
| Creatinine ≥2 | 1.10 | (0.80–1.50) | 0.6 |
| Preoperative dialysis | 1.26 | (0.74–2.13) | 0.4 |
| Zubrod score (reference: 0) | |||
| 1 | 1.16 | (1.06–1.27) | 0.001 |
| 2 or 3 | 1.35 | (1.12–1.62) | 0.001 |
| ASA class (reference: I or II) | |||
| III | 1.23 | (1.07–1.40) | 0.003 |